Medical Care

Global Viral Vector Purification Market Research Report 2025

The global market for Viral Vector Purification was valued at US$ 8178 million in the year 2024 and is projected to reach a revised size of US$ 19250 million by 2031, growing at a CAGR of 13.2% during the forecast period.
Viral vector purification is a critical step in the production of gene therapy and vaccine products that utilize viral vectors. Viral vectors are vehicles used to deliver genetic material (e.g., therapeutic genes, antigens) into target cells for various applications, including gene therapy and vaccination. The purification process is necessary to isolate and concentrate the viral vectors while removing impurities and contaminants. The goal is to produce a highly purified and potent viral vector product for safe and effective use in patients.
There is a trend toward the development of automated purification processes that can handle larger volumes and improve overall efficiency. High-throughput purification methods can be crucial for meeting the increasing demand for viral vectors in clinical and commercial applications.
This report aims to provide a comprehensive presentation of the global market for Viral Vector Purification, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vector Purification.
The Viral Vector Purification market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Viral Vector Purification market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viral Vector Purification companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Applied Biological Materials Inc.
Creative Biolabs
Bio-Rad Laboratories, Inc.
Sirion-Biotech GmbH
Merck KGaA
FUJIFILM Diosynth Biotechnologies
Batavia Biosciences B.V.
Agilent Technologies, Inc.
Addgene
IDT Biologika GmbH
ProBioGen AG
Takara Bio Inc.
Thermo Fisher Scientific Inc.,
Waisman Biomanufacturing
Creative Biogene
Aldevron
BioVision Inc.
Segment by Type
In Vivo
In Vitro
Segment by Application
Gene Therapy
Cell Therapy
Vaccinology
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Viral Vector Purification company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vector Purification Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 In Vivo
1.2.3 In Vitro
1.3 Market by Application
1.3.1 Global Viral Vector Purification Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Gene Therapy
1.3.3 Cell Therapy
1.3.4 Vaccinology
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Vector Purification Market Perspective (2020-2031)
2.2 Global Viral Vector Purification Growth Trends by Region
2.2.1 Global Viral Vector Purification Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Viral Vector Purification Historic Market Size by Region (2020-2025)
2.2.3 Viral Vector Purification Forecasted Market Size by Region (2026-2031)
2.3 Viral Vector Purification Market Dynamics
2.3.1 Viral Vector Purification Industry Trends
2.3.2 Viral Vector Purification Market Drivers
2.3.3 Viral Vector Purification Market Challenges
2.3.4 Viral Vector Purification Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Vector Purification Players by Revenue
3.1.1 Global Top Viral Vector Purification Players by Revenue (2020-2025)
3.1.2 Global Viral Vector Purification Revenue Market Share by Players (2020-2025)
3.2 Global Viral Vector Purification Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Viral Vector Purification Revenue
3.4 Global Viral Vector Purification Market Concentration Ratio
3.4.1 Global Viral Vector Purification Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vector Purification Revenue in 2024
3.5 Global Key Players of Viral Vector Purification Head office and Area Served
3.6 Global Key Players of Viral Vector Purification, Product and Application
3.7 Global Key Players of Viral Vector Purification, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vector Purification Breakdown Data by Type
4.1 Global Viral Vector Purification Historic Market Size by Type (2020-2025)
4.2 Global Viral Vector Purification Forecasted Market Size by Type (2026-2031)
5 Viral Vector Purification Breakdown Data by Application
5.1 Global Viral Vector Purification Historic Market Size by Application (2020-2025)
5.2 Global Viral Vector Purification Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Viral Vector Purification Market Size (2020-2031)
6.2 North America Viral Vector Purification Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Viral Vector Purification Market Size by Country (2020-2025)
6.4 North America Viral Vector Purification Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Vector Purification Market Size (2020-2031)
7.2 Europe Viral Vector Purification Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Viral Vector Purification Market Size by Country (2020-2025)
7.4 Europe Viral Vector Purification Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Vector Purification Market Size (2020-2031)
8.2 Asia-Pacific Viral Vector Purification Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Viral Vector Purification Market Size by Region (2020-2025)
8.4 Asia-Pacific Viral Vector Purification Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Vector Purification Market Size (2020-2031)
9.2 Latin America Viral Vector Purification Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Viral Vector Purification Market Size by Country (2020-2025)
9.4 Latin America Viral Vector Purification Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Vector Purification Market Size (2020-2031)
10.2 Middle East & Africa Viral Vector Purification Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Viral Vector Purification Market Size by Country (2020-2025)
10.4 Middle East & Africa Viral Vector Purification Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Applied Biological Materials Inc.
11.1.1 Applied Biological Materials Inc. Company Details
11.1.2 Applied Biological Materials Inc. Business Overview
11.1.3 Applied Biological Materials Inc. Viral Vector Purification Introduction
11.1.4 Applied Biological Materials Inc. Revenue in Viral Vector Purification Business (2020-2025)
11.1.5 Applied Biological Materials Inc. Recent Development
11.2 Creative Biolabs
11.2.1 Creative Biolabs Company Details
11.2.2 Creative Biolabs Business Overview
11.2.3 Creative Biolabs Viral Vector Purification Introduction
11.2.4 Creative Biolabs Revenue in Viral Vector Purification Business (2020-2025)
11.2.5 Creative Biolabs Recent Development
11.3 Bio-Rad Laboratories, Inc.
11.3.1 Bio-Rad Laboratories, Inc. Company Details
11.3.2 Bio-Rad Laboratories, Inc. Business Overview
11.3.3 Bio-Rad Laboratories, Inc. Viral Vector Purification Introduction
11.3.4 Bio-Rad Laboratories, Inc. Revenue in Viral Vector Purification Business (2020-2025)
11.3.5 Bio-Rad Laboratories, Inc. Recent Development
11.4 Sirion-Biotech GmbH
11.4.1 Sirion-Biotech GmbH Company Details
11.4.2 Sirion-Biotech GmbH Business Overview
11.4.3 Sirion-Biotech GmbH Viral Vector Purification Introduction
11.4.4 Sirion-Biotech GmbH Revenue in Viral Vector Purification Business (2020-2025)
11.4.5 Sirion-Biotech GmbH Recent Development
11.5 Merck KGaA
11.5.1 Merck KGaA Company Details
11.5.2 Merck KGaA Business Overview
11.5.3 Merck KGaA Viral Vector Purification Introduction
11.5.4 Merck KGaA Revenue in Viral Vector Purification Business (2020-2025)
11.5.5 Merck KGaA Recent Development
11.6 FUJIFILM Diosynth Biotechnologies
11.6.1 FUJIFILM Diosynth Biotechnologies Company Details
11.6.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.6.3 FUJIFILM Diosynth Biotechnologies Viral Vector Purification Introduction
11.6.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector Purification Business (2020-2025)
11.6.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.7 Batavia Biosciences B.V.
11.7.1 Batavia Biosciences B.V. Company Details
11.7.2 Batavia Biosciences B.V. Business Overview
11.7.3 Batavia Biosciences B.V. Viral Vector Purification Introduction
11.7.4 Batavia Biosciences B.V. Revenue in Viral Vector Purification Business (2020-2025)
11.7.5 Batavia Biosciences B.V. Recent Development
11.8 Agilent Technologies, Inc.
11.8.1 Agilent Technologies, Inc. Company Details
11.8.2 Agilent Technologies, Inc. Business Overview
11.8.3 Agilent Technologies, Inc. Viral Vector Purification Introduction
11.8.4 Agilent Technologies, Inc. Revenue in Viral Vector Purification Business (2020-2025)
11.8.5 Agilent Technologies, Inc. Recent Development
11.9 Addgene
11.9.1 Addgene Company Details
11.9.2 Addgene Business Overview
11.9.3 Addgene Viral Vector Purification Introduction
11.9.4 Addgene Revenue in Viral Vector Purification Business (2020-2025)
11.9.5 Addgene Recent Development
11.10 IDT Biologika GmbH
11.10.1 IDT Biologika GmbH Company Details
11.10.2 IDT Biologika GmbH Business Overview
11.10.3 IDT Biologika GmbH Viral Vector Purification Introduction
11.10.4 IDT Biologika GmbH Revenue in Viral Vector Purification Business (2020-2025)
11.10.5 IDT Biologika GmbH Recent Development
11.11 ProBioGen AG
11.11.1 ProBioGen AG Company Details
11.11.2 ProBioGen AG Business Overview
11.11.3 ProBioGen AG Viral Vector Purification Introduction
11.11.4 ProBioGen AG Revenue in Viral Vector Purification Business (2020-2025)
11.11.5 ProBioGen AG Recent Development
11.12 Takara Bio Inc.
11.12.1 Takara Bio Inc. Company Details
11.12.2 Takara Bio Inc. Business Overview
11.12.3 Takara Bio Inc. Viral Vector Purification Introduction
11.12.4 Takara Bio Inc. Revenue in Viral Vector Purification Business (2020-2025)
11.12.5 Takara Bio Inc. Recent Development
11.13 Thermo Fisher Scientific Inc.,
11.13.1 Thermo Fisher Scientific Inc., Company Details
11.13.2 Thermo Fisher Scientific Inc., Business Overview
11.13.3 Thermo Fisher Scientific Inc., Viral Vector Purification Introduction
11.13.4 Thermo Fisher Scientific Inc., Revenue in Viral Vector Purification Business (2020-2025)
11.13.5 Thermo Fisher Scientific Inc., Recent Development
11.14 Waisman Biomanufacturing
11.14.1 Waisman Biomanufacturing Company Details
11.14.2 Waisman Biomanufacturing Business Overview
11.14.3 Waisman Biomanufacturing Viral Vector Purification Introduction
11.14.4 Waisman Biomanufacturing Revenue in Viral Vector Purification Business (2020-2025)
11.14.5 Waisman Biomanufacturing Recent Development
11.15 Creative Biogene
11.15.1 Creative Biogene Company Details
11.15.2 Creative Biogene Business Overview
11.15.3 Creative Biogene Viral Vector Purification Introduction
11.15.4 Creative Biogene Revenue in Viral Vector Purification Business (2020-2025)
11.15.5 Creative Biogene Recent Development
11.16 Aldevron
11.16.1 Aldevron Company Details
11.16.2 Aldevron Business Overview
11.16.3 Aldevron Viral Vector Purification Introduction
11.16.4 Aldevron Revenue in Viral Vector Purification Business (2020-2025)
11.16.5 Aldevron Recent Development
11.17 BioVision Inc.
11.17.1 BioVision Inc. Company Details
11.17.2 BioVision Inc. Business Overview
11.17.3 BioVision Inc. Viral Vector Purification Introduction
11.17.4 BioVision Inc. Revenue in Viral Vector Purification Business (2020-2025)
11.17.5 BioVision Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Viral Vector Purification Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of In Vivo
Table 3. Key Players of In Vitro
Table 4. Global Viral Vector Purification Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Viral Vector Purification Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Viral Vector Purification Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Viral Vector Purification Market Share by Region (2020-2025)
Table 8. Global Viral Vector Purification Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Viral Vector Purification Market Share by Region (2026-2031)
Table 10. Viral Vector Purification Market Trends
Table 11. Viral Vector Purification Market Drivers
Table 12. Viral Vector Purification Market Challenges
Table 13. Viral Vector Purification Market Restraints
Table 14. Global Viral Vector Purification Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Viral Vector Purification Market Share by Players (2020-2025)
Table 16. Global Top Viral Vector Purification Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Purification as of 2024)
Table 17. Ranking of Global Top Viral Vector Purification Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Viral Vector Purification Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Viral Vector Purification, Headquarters and Area Served
Table 20. Global Key Players of Viral Vector Purification, Product and Application
Table 21. Global Key Players of Viral Vector Purification, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Viral Vector Purification Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Viral Vector Purification Revenue Market Share by Type (2020-2025)
Table 25. Global Viral Vector Purification Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Viral Vector Purification Revenue Market Share by Type (2026-2031)
Table 27. Global Viral Vector Purification Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Viral Vector Purification Revenue Market Share by Application (2020-2025)
Table 29. Global Viral Vector Purification Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Viral Vector Purification Revenue Market Share by Application (2026-2031)
Table 31. North America Viral Vector Purification Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Viral Vector Purification Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Viral Vector Purification Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Viral Vector Purification Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Viral Vector Purification Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Viral Vector Purification Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Viral Vector Purification Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Viral Vector Purification Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Viral Vector Purification Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Viral Vector Purification Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Viral Vector Purification Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Viral Vector Purification Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Viral Vector Purification Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Viral Vector Purification Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Viral Vector Purification Market Size by Country (2026-2031) & (US$ Million)
Table 46. Applied Biological Materials Inc. Company Details
Table 47. Applied Biological Materials Inc. Business Overview
Table 48. Applied Biological Materials Inc. Viral Vector Purification Product
Table 49. Applied Biological Materials Inc. Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)
Table 50. Applied Biological Materials Inc. Recent Development
Table 51. Creative Biolabs Company Details
Table 52. Creative Biolabs Business Overview
Table 53. Creative Biolabs Viral Vector Purification Product
Table 54. Creative Biolabs Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)
Table 55. Creative Biolabs Recent Development
Table 56. Bio-Rad Laboratories, Inc. Company Details
Table 57. Bio-Rad Laboratories, Inc. Business Overview
Table 58. Bio-Rad Laboratories, Inc. Viral Vector Purification Product
Table 59. Bio-Rad Laboratories, Inc. Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)
Table 60. Bio-Rad Laboratories, Inc. Recent Development
Table 61. Sirion-Biotech GmbH Company Details
Table 62. Sirion-Biotech GmbH Business Overview
Table 63. Sirion-Biotech GmbH Viral Vector Purification Product
Table 64. Sirion-Biotech GmbH Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)
Table 65. Sirion-Biotech GmbH Recent Development
Table 66. Merck KGaA Company Details
Table 67. Merck KGaA Business Overview
Table 68. Merck KGaA Viral Vector Purification Product
Table 69. Merck KGaA Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)
Table 70. Merck KGaA Recent Development
Table 71. FUJIFILM Diosynth Biotechnologies Company Details
Table 72. FUJIFILM Diosynth Biotechnologies Business Overview
Table 73. FUJIFILM Diosynth Biotechnologies Viral Vector Purification Product
Table 74. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)
Table 75. FUJIFILM Diosynth Biotechnologies Recent Development
Table 76. Batavia Biosciences B.V. Company Details
Table 77. Batavia Biosciences B.V. Business Overview
Table 78. Batavia Biosciences B.V. Viral Vector Purification Product
Table 79. Batavia Biosciences B.V. Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)
Table 80. Batavia Biosciences B.V. Recent Development
Table 81. Agilent Technologies, Inc. Company Details
Table 82. Agilent Technologies, Inc. Business Overview
Table 83. Agilent Technologies, Inc. Viral Vector Purification Product
Table 84. Agilent Technologies, Inc. Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)
Table 85. Agilent Technologies, Inc. Recent Development
Table 86. Addgene Company Details
Table 87. Addgene Business Overview
Table 88. Addgene Viral Vector Purification Product
Table 89. Addgene Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)
Table 90. Addgene Recent Development
Table 91. IDT Biologika GmbH Company Details
Table 92. IDT Biologika GmbH Business Overview
Table 93. IDT Biologika GmbH Viral Vector Purification Product
Table 94. IDT Biologika GmbH Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)
Table 95. IDT Biologika GmbH Recent Development
Table 96. ProBioGen AG Company Details
Table 97. ProBioGen AG Business Overview
Table 98. ProBioGen AG Viral Vector Purification Product
Table 99. ProBioGen AG Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)
Table 100. ProBioGen AG Recent Development
Table 101. Takara Bio Inc. Company Details
Table 102. Takara Bio Inc. Business Overview
Table 103. Takara Bio Inc. Viral Vector Purification Product
Table 104. Takara Bio Inc. Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)
Table 105. Takara Bio Inc. Recent Development
Table 106. Thermo Fisher Scientific Inc., Company Details
Table 107. Thermo Fisher Scientific Inc., Business Overview
Table 108. Thermo Fisher Scientific Inc., Viral Vector Purification Product
Table 109. Thermo Fisher Scientific Inc., Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)
Table 110. Thermo Fisher Scientific Inc., Recent Development
Table 111. Waisman Biomanufacturing Company Details
Table 112. Waisman Biomanufacturing Business Overview
Table 113. Waisman Biomanufacturing Viral Vector Purification Product
Table 114. Waisman Biomanufacturing Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)
Table 115. Waisman Biomanufacturing Recent Development
Table 116. Creative Biogene Company Details
Table 117. Creative Biogene Business Overview
Table 118. Creative Biogene Viral Vector Purification Product
Table 119. Creative Biogene Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)
Table 120. Creative Biogene Recent Development
Table 121. Aldevron Company Details
Table 122. Aldevron Business Overview
Table 123. Aldevron Viral Vector Purification Product
Table 124. Aldevron Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)
Table 125. Aldevron Recent Development
Table 126. BioVision Inc. Company Details
Table 127. BioVision Inc. Business Overview
Table 128. BioVision Inc. Viral Vector Purification Product
Table 129. BioVision Inc. Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)
Table 130. BioVision Inc. Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 134. Authors List of This Report


List of Figures
Figure 1. Viral Vector Purification Picture
Figure 2. Global Viral Vector Purification Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Viral Vector Purification Market Share by Type: 2024 VS 2031
Figure 4. In Vivo Features
Figure 5. In Vitro Features
Figure 6. Global Viral Vector Purification Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Viral Vector Purification Market Share by Application: 2024 VS 2031
Figure 8. Gene Therapy Case Studies
Figure 9. Cell Therapy Case Studies
Figure 10. Vaccinology Case Studies
Figure 11. Viral Vector Purification Report Years Considered
Figure 12. Global Viral Vector Purification Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Viral Vector Purification Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Viral Vector Purification Market Share by Region: 2024 VS 2031
Figure 15. Global Viral Vector Purification Market Share by Players in 2024
Figure 16. Global Top Viral Vector Purification Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Purification as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Viral Vector Purification Revenue in 2024
Figure 18. North America Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Viral Vector Purification Market Share by Country (2020-2031)
Figure 20. United States Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Viral Vector Purification Market Share by Country (2020-2031)
Figure 24. Germany Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Viral Vector Purification Market Share by Region (2020-2031)
Figure 32. China Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Viral Vector Purification Market Share by Country (2020-2031)
Figure 40. Mexico Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Viral Vector Purification Market Share by Country (2020-2031)
Figure 44. Turkey Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Applied Biological Materials Inc. Revenue Growth Rate in Viral Vector Purification Business (2020-2025)
Figure 48. Creative Biolabs Revenue Growth Rate in Viral Vector Purification Business (2020-2025)
Figure 49. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Viral Vector Purification Business (2020-2025)
Figure 50. Sirion-Biotech GmbH Revenue Growth Rate in Viral Vector Purification Business (2020-2025)
Figure 51. Merck KGaA Revenue Growth Rate in Viral Vector Purification Business (2020-2025)
Figure 52. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vector Purification Business (2020-2025)
Figure 53. Batavia Biosciences B.V. Revenue Growth Rate in Viral Vector Purification Business (2020-2025)
Figure 54. Agilent Technologies, Inc. Revenue Growth Rate in Viral Vector Purification Business (2020-2025)
Figure 55. Addgene Revenue Growth Rate in Viral Vector Purification Business (2020-2025)
Figure 56. IDT Biologika GmbH Revenue Growth Rate in Viral Vector Purification Business (2020-2025)
Figure 57. ProBioGen AG Revenue Growth Rate in Viral Vector Purification Business (2020-2025)
Figure 58. Takara Bio Inc. Revenue Growth Rate in Viral Vector Purification Business (2020-2025)
Figure 59. Thermo Fisher Scientific Inc., Revenue Growth Rate in Viral Vector Purification Business (2020-2025)
Figure 60. Waisman Biomanufacturing Revenue Growth Rate in Viral Vector Purification Business (2020-2025)
Figure 61. Creative Biogene Revenue Growth Rate in Viral Vector Purification Business (2020-2025)
Figure 62. Aldevron Revenue Growth Rate in Viral Vector Purification Business (2020-2025)
Figure 63. BioVision Inc. Revenue Growth Rate in Viral Vector Purification Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies